Mammalian Transient Protein Expression Market Size & Share, by Product (Instruments, Expression Vector, Reagents & Consumables, Cell Lines); Application (Bio-production, Functional Cell-Based Assays, Academic Research); End-user (Contract Research Organizations, Biopharmaceutical Companies, Academic & Research Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

Request Free Sample Copy

Report ID: 4560
Published Date: Feb 24, 2023
Report Format: PDF, PPT

Buy Now

Companies Dominating the Mammalian Transient Protein Expression Landscape

Thermo Fisher Scientific Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Merck KGaA
Promega Corporation
Lonza Group
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
QIAGEN GmbH
Takara Bio India Pvt. Ltd.
HiMedia Laboratories Pvt Ltd
Sino Biological, Inc.

Browse Key Market Insights with Data Illustration:

Mammalian Transient Protein Expression Market Analysis - Growth Outlook 2033

In the News

Merck KgaA announced its expansion in October 2020, with the opening of a new membrane production plant in Darmstadt, Germany. The goal was to increase the production of Millipore Express membranes, which aid in the sterility of biological drug products.
Agilent Technologies, Inc. to become the partner with Akoya Biosciences, Inc. to develop multiplex-immunohistochemistry diagnostic solutions. This solution will be helpful for tissue analysis to commercialize this solution.

Frequently Asked Questions (FAQ)

Increasing health expenditure across the global population are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2023-2033.

Lack of expert healthcare professionals to handle the therapeutic protein generation are estimated to be the growth hindering factors for the market expansion.

The market in North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Merck KGaA, Promega Corporation, Lonza Group, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., QIAGEN GmbH, Takara Bio India Pvt. Ltd., HiMedia Laboratories Pvt. Ltd, Sino Biological, Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, application, end-user, and by region.

The contract research organizations segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.

Companies Dominating the Mammalian Transient Protein Expression Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the mammalian transient protein expression market?

What would be the CAGR of mammalian transient protein expression market over the forecast period?

What are the challenges affecting the mammalian transient protein expression market growth?

Which region will provide more business opportunities for growth of mammalian transient protein expression market in future?

Who are the major players dominating the mammalian transient protein expression market?

How are the company profiles selected?

What are the segments in the mammalian transient protein expression market?

Which segment captures the largest market size in the end user segment in the mammalian transient protein expression market?6) Which segment captures the largest market size in the end user segment in the mammalian transient protein expression market?